These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 25650695)
21. Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study. Revicki DA; Menter A; Feldman S; Kimel M; Harnam N; Willian MK Health Qual Life Outcomes; 2008 Oct; 6():75. PubMed ID: 18831744 [TBL] [Abstract][Full Text] [Related]
22. Reflectance confocal microscopy for plaque psoriasis therapeutic follow-up during an anti-TNF-α monoclonal antibody: an observational multicenter study. Ardigò M; Agozzino M; Longo C; Lallas A; Di Lernia V; Fabiano A; Conti A; Sperduti I; Argenziano G; Berardesca E; Pellacani G J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2363-8. PubMed ID: 26299420 [TBL] [Abstract][Full Text] [Related]
23. Parallel downregulation of retinol-binding protein-4 and adiponectin expression in subcutaneous adipose tissue of non-morbidly obese subjects. Broch M; Auguet MT; Ramírez R; Olona M; Aguilar C; Megia A; Alcaide MJ; Pastor R; Martínez S; Caubet E; Garcia-España A; Richart C Eur J Endocrinol; 2009 Jul; 161(1):87-94. PubMed ID: 19369430 [TBL] [Abstract][Full Text] [Related]
24. Circulating retinol binding protein 4 is associated with coronary lesion severity of patients with coronary artery disease. Liu Y; Wang D; Chen H; Xia M Atherosclerosis; 2015 Jan; 238(1):45-51. PubMed ID: 25437889 [TBL] [Abstract][Full Text] [Related]
25. Association of plasma retinol-binding protein-4, adiponectin, and high molecular weight adiponectin with metabolic adversities in patients with schizophrenia. Chen PY; Huang MC; Chiu CC; Liu HC; Lu ML; Chen CH Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1927-32. PubMed ID: 21840365 [TBL] [Abstract][Full Text] [Related]
26. Mechanistic target of rapamycin complex 1 is involved in psoriasis and regulated by anti-TNF-α treatment. Balato A; Lembo S; Ayala F; Balato N; Caiazzo G; Raimondo A; Di Caprio R; Monfrecola G Exp Dermatol; 2017 Apr; 26(4):325-327. PubMed ID: 27943462 [No Abstract] [Full Text] [Related]
27. Pathway Analysis of Skin from Psoriasis Patients after Adalimumab Treatment Reveals New Early Events in the Anti-Inflammatory Mechanism of Anti-TNF-α. Langkilde A; Olsen LC; Sætrom P; Drabløs F; Besenbacher S; Raaby L; Johansen C; Iversen L PLoS One; 2016; 11(12):e0167437. PubMed ID: 28005985 [TBL] [Abstract][Full Text] [Related]
28. The Association between Clinical Response to Ustekinumab and Immunogenicity to Ustekinumab and Prior Adalimumab. Chiu HY; Chu TW; Cheng YP; Tsai TF PLoS One; 2015; 10(11):e0142930. PubMed ID: 26566272 [TBL] [Abstract][Full Text] [Related]
29. TNF-α in a molecularly targeted therapy of psoriasis and psoriatic arthritis. Wcisło-Dziadecka D; Zbiciak-Nylec M; Brzezińska-Wcisło L; Mazurek U Postgrad Med J; 2016 Mar; 92(1085):172-8. PubMed ID: 26719452 [TBL] [Abstract][Full Text] [Related]
30. Serum Carotenoids Are Inversely Associated with RBP4 and Other Inflammatory Markers in Middle-Aged and Elderly Adults. Jing L; Xiao M; Dong H; Lin J; Chen G; Ling W; Chen Y Nutrients; 2018 Feb; 10(3):. PubMed ID: 29495330 [TBL] [Abstract][Full Text] [Related]
31. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. Qi Q; Yu Z; Ye X; Zhao F; Huang P; Hu FB; Franco OH; Wang J; Li H; Liu Y; Lin X J Clin Endocrinol Metab; 2007 Dec; 92(12):4827-34. PubMed ID: 17878249 [TBL] [Abstract][Full Text] [Related]
32. The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities. Piérard GE; Piérard-Franchimont C; Szepetiuk G; Paquet P; Quatresooz P Expert Opin Biol Ther; 2010 Aug; 10(8):1197-208. PubMed ID: 20560729 [TBL] [Abstract][Full Text] [Related]
33. High Levels of Platelet-Lymphocyte Complexes in Patients with Psoriasis Are Associated with a Better Response to Anti-TNF-α Therapy. Sanz-Martínez MT; Moga E; Sánchez Martínez MA; Zamora Atenza C; Vidal S; Juárez C; Puig L J Invest Dermatol; 2020 Jun; 140(6):1176-1183. PubMed ID: 31778714 [TBL] [Abstract][Full Text] [Related]
34. Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol binding protein-4 level in obstructive sleep apnea syndrome. Makino S; Fujiwara M; Suzukawa K; Handa H; Fujie T; Ohtaka Y; Komatsu Y; Aoki Y; Maruyama H; Terada Y; Hashimoto K; Sugimoto T Horm Metab Res; 2009 Mar; 41(3):221-6. PubMed ID: 19003725 [TBL] [Abstract][Full Text] [Related]
35. Recalcitrant psoriatic uveitis and anti-tumor necrosis factor-α monoclonal antibodies: experience from a psoriasis referral center. Fotiadou C; Lazaridou E; Kemanetzi C; Kyrmanidou E; Ioannides D Int J Dermatol; 2015 Sep; 54(9):1105-8. PubMed ID: 25557117 [TBL] [Abstract][Full Text] [Related]
36. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Wu H; Jia W; Bao Y; Lu J; Zhu J; Wang R; Chen Y; Xiang K Diabetes Res Clin Pract; 2008 Feb; 79(2):185-90. PubMed ID: 17904683 [TBL] [Abstract][Full Text] [Related]
37. Serum FGF21 and RBP4 levels in patients with chronic hepatitis C. Kukla M; Berdowska A; Stygar D; Gabriel A; Mazur W; Łogiewa-Bazger B; Sobala-Szczygieł B; Bułdak RJ; Rokitka M; Zajęcki W; Kępa L; Sawczyn T; Zwirska-Korczala K Scand J Gastroenterol; 2012 Sep; 47(8-9):1037-47. PubMed ID: 22670657 [TBL] [Abstract][Full Text] [Related]
38. Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis. Saraceno R; Schipani C; Mazzotta A; Esposito M; Di Renzo L; De Lorenzo A; Chimenti S Pharmacol Res; 2008 Apr; 57(4):290-5. PubMed ID: 18400510 [TBL] [Abstract][Full Text] [Related]
39. Correlation between trough serum levels of adalimumab and absolute PASI score in a series of patients with psoriasis. Carrascosa JM; Toro Montecinos M; Ballescá F; Teniente Serra A; Martínez Cáceres E; Ferrándiz C J Dermatolog Treat; 2018 Mar; 29(2):140-144. PubMed ID: 28604127 [TBL] [Abstract][Full Text] [Related]
40. Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome. Möhlig M; Weickert MO; Ghadamgahi E; Arafat AM; Spranger J; Pfeiffer AF; Schöfl C Eur J Endocrinol; 2008 Apr; 158(4):517-23. PubMed ID: 18362299 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]